Journal of Antimicrobial Chemotherapy

Leading articles:

ALASDAIR MACGOWAN

Concentration controlled and concentration defined clinical trials: do they offer any advantages for antimicrobial chemotherapy?: J Antimicrob Chemother 1996; 37: 1–5
J. Antimicrob. Chemother. 1996 37: 1-5; doi:10.1093/jac/37.1.1 [PDF] [Request Permissions]  

P. D. O. DAVIES

Multiple drug resistant tuberculosis: centralized mycobacterial reference using molecular techniques can help: J Antimicrob Chemother 1996; 37: 5–6
J. Antimicrob. Chemother. 1996 37: 5-6; doi:10.1093/jac/37.1.5 [PDF] [Request Permissions]  

Review:

A. G. Hutt and J. O'Grady

Drug chirality: a consideration of the significance of the stereochemistry of antimicrobial agents
J. Antimicrob. Chemother. 1996 37: 7-32; doi:10.1093/jac/37.1.7 [Abstract] [PDF] [Request Permissions]  

Original articles:

M. V. Hayes, C. J. Thomson, and S. G. B. Amyes

The "hidden" carbapenemase of Aeromonas hydrophila
J. Antimicrob. Chemother. 1996 37: 33-44; doi:10.1093/jac/37.1.33 [Abstract] [PDF] [Request Permissions]  

R. Ansorg, G. von Recklinghausen, and E. Heintschel von Heinegg

Susceptibility of Helicobacter pylori to simethicone and other non-antibiotic drugs
J. Antimicrob. Chemother. 1996 37: 45-52; doi:10.1093/jac/37.1.45 [Abstract] [PDF] [Request Permissions]  

G. E. Bignardi, N. Woodford, A. Chapman, A. P. Johnson, and D. C. E. Speller

Detection of the mec-A gene and phenotypic detection of resistance in Staphylococcus aureus isolates with borderline or low-level methicillin resistance
J. Antimicrob. Chemother. 1996 37: 53-63; doi:10.1093/jac/37.1.53 [Abstract] [PDF] [Request Permissions]  

Dimitra Gennimata, Julian Davies, and S. Tsiftsoglour

Bleomycin resistance in Staphylococcus aureus clinical isolates
J. Antimicrob. Chemother. 1996 37: 65-75; doi:10.1093/jac/37.1.65 [Abstract] [PDF] [Request Permissions]  

M. A. Visalli, M. R. Jacobs, and P. C. Appelbaum

Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and pencillin-resistant pneumococci by time-kill methodology
J. Antimicrob. Chemother. 1996 37: 77-84; doi:10.1093/jac/37.1.77 [Abstract] [PDF] [Request Permissions]  

J. A. Frost, A. Kelleher, and B. Rowe

Increasing ciprofloxacin resistance in salmonellas in England and Wales 1991–1994
J. Antimicrob. Chemother. 1996 37: 85-91; doi:10.1093/jac/37.1.85 [Abstract] [PDF] [Request Permissions]  

W. S. Shin, C. K. Min, Y. R. Kim, J. H. Yoo, and M. W. Kang

In-vitro effects of cefodizime of leucocyte functions and colony formation from granulocyte-monocyte progenitors
J. Antimicrob. Chemother. 1996 37: 93-103; doi:10.1093/jac/37.1.93 [Abstract] [PDF] [Request Permissions]  

Olivier Balland, Huguette Pinto-Alphandary, Annie Viron, Edmond Puvion, Antoine Andremont, and Patrick Couvreur

Intracellular distribution of ampicillin in murine macrophages infected with Salmonella typhimurium and treated with (³H)ampicillin-loaded nanoparticles
J. Antimicrob. Chemother. 1996 37: 105-115; doi:10.1093/jac/37.1.105 [Abstract] [PDF] [Request Permissions]  

Paul H. Edelstein, Martha A. C. Edelstein, K. H. Lehr, and Jianjun Ren

In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia
J. Antimicrob. Chemother. 1996 37: 117-126; doi:10.1093/jac/37.1.117 [Abstract] [PDF] [Request Permissions]  

Muhammad M. Zaman, David Landman, Sibte Burney, and John M. Quale

Treatment of experimental endocarditis due to multidrug-resistant Enterococcus faecium with clinafloxzcin and penicillin
J. Antimicrob. Chemother. 1996 37: 127-132; doi:10.1093/jac/37.1.127 [Abstract] [PDF] [Request Permissions]  

R. S. Dykhuizen, D. Golder, T. M. S. Reid, and I. M. Gould

Phenoxymethyl penicillin versus co-amoxiclav in the treatment of acute streptococcal pharyngitis, and the role of ß-lactamase activity in saliva
J. Antimicrob. Chemother. 1996 37: 133-138; doi:10.1093/jac/37.1.133 [Abstract] [PDF] [Request Permissions]  

Brief reports:

David L. Sewell, Arthur L. Barry, Stephen D. Allen, Peter C. Fuchs, Patrick R. Murray, and Fred C. Tenover

Tentative interpretive criteria and quality control parameters for in-vitro susceptibility testing of Neisseria gonorrhoeae to two fluoroquinolones (PD 131628 and grepafloxacin (OPC 17116))
J. Antimicrob. Chemother. 1996 37: 139-143; doi:10.1093/jac/37.1.139 [Abstract] [PDF] [Request Permissions]  

D. Jonkers, E. Stobberingh, and R. Stockbrügger

Omeprazole inhibis growth of Gram-positive and Gram-negative bacteria including Helicobacter pylori in vitro
J. Antimicrob. Chemother. 1996 37: 145-150; doi:10.1093/jac/37.1.145 [Abstract] [PDF] [Request Permissions]  

C. Sánchez-Carrillo, M. Cotarelo, E. Cercenado, T. Vicente, R. Blázquez, and E. Bouza

Comparative in-vitro activity of sparfloxacin and eight other antimicrobial agents against clinical isolates of non-tuberculous mycobacteria
J. Antimicrob. Chemother. 1996 37: 151-154; doi:10.1093/jac/37.1.151 [Abstract] [PDF] [Request Permissions]  

G. Aubert, D. Guichard, and G. Vedel

In-vitro activity of cephalosporins alone and combined with sulbactam against various strains of Acinetobacter baumannii with different antibiotic resistance profiles
J. Antimicrob. Chemother. 1996 37: 155-160; doi:10.1093/jac/37.1.155 [Abstract] [PDF] [Request Permissions]  

T. Kossmann, V. Hans, R. Stocker, H.-G Imhof, B. Joos, O. Trentz, and M. C. Morganti-Kossmann

Penetration of cefuroxime into the cerebrospinal fluid of patients with traumatic brain injury
J. Antimicrob. Chemother. 1996 37: 161-167; doi:10.1093/jac/37.1.161 [Abstract] [PDF] [Request Permissions]  

Tiina Leistevuo, Monica Österblad, Päivi Toivonen, Anja Kahra, Aapo Lehtonen, and Pentti Huovinen

Colonization of resistant faecal aerobic Gram-negative bacilli among geriatric patients in hospital and the community
J. Antimicrob. Chemother. 1996 37: 169-173; doi:10.1093/jac/37.1.169 [Abstract] [PDF] [Request Permissions]  

Antimicrobial practice:

Félix Gutiérrez, Patrick G. Wall, and Jonathan Cohen

An audit of the use of antifungal agents
J. Antimicrob. Chemother. 1996 37: 175-185; doi:10.1093/jac/37.1.175 [Abstract] [PDF] [Request Permissions]  

Correspondence:

J. M. ANDREWS, D. BROWN, and R. WISE

A survey of antimicrobial susceptibility testing in the United Kingdom
J. Antimicrob. Chemother. 1996 37: 187-188; doi:10.1093/jac/37.1.187 [PDF] [Request Permissions]  

PAUL ANTHONY MAJCHERCZYK

The issue of the true postantibiotic effect
J. Antimicrob. Chemother. 1996 37: 188-189; doi:10.1093/jac/37.1.188 [PDF] [Request Permissions]  

G. G. ZHANEL

Reply
J. Antimicrob. Chemother. 1996 37: 189-190; doi:10.1093/jac/37.1.189 [PDF] [Request Permissions]  

E B. CHAIBI, S. FARZANEH, A. MORAND, J. PEDUZZI, M. BARTHELEMY, D. SIROT, and R. LABIA

Problems encountered in the characterization of IRT ß-lactamase-producing clinical Escherichia coil isolates intermediate-resistant to cephalothin
J. Antimicrob. Chemother. 1996 37: 190-191; doi:10.1093/jac/37.1.190 [PDF] [Request Permissions]  

A H. ADRIAANSE, H. L. MUYTJENS, F. W. A. HEESSEN, J. M. D. GALAMA, and J. A. A. HOOGKAMP-KORSTANJE

In-vitro activity of chlorhexidine, hexetidine and bacitracin against perinatal pathogens
J. Antimicrob. Chemother. 1996 37: 192-194; doi:10.1093/jac/37.1.192 [PDF] [Request Permissions]  

O. GAILLOT, M. MALLEA, A. PHILIPPON, J.-M. PAGES, and M. SIMONET

Paradoxical susceptibility to cephalothin and cefamandole of a Klebsiella pneumoniae isolate producing extended-spectrum ß-lactamase (TEM-3)
J. Antimicrob. Chemother. 1996 37: 194-196; doi:10.1093/jac/37.1.194 [PDF] [Request Permissions]  

M. V REDDY, GEETA NADADHUR, and PATTISAPU R. J. GANGADHARAM

In-vitro and intracellular antimycobacterial activity of trifluoperazine
J. Antimicrob. Chemother. 1996 37: 196-197; doi:10.1093/jac/37.1.196 [PDF] [Request Permissions]  

JERONIMO PACHON, DOLORES PRADOS, JULIAN PALOMINO, ANGEL CANTOS, JOSE M. CISNEROS, and FERNANDO VAQUERO

Efficacy and safety of teicoplanin in infections caused by methicillin-resistant Staphylococcus aureus
J. Antimicrob. Chemother. 1996 37: 197-200; doi:10.1093/jac/37.1.197 [PDF] [Request Permissions]  

VICTOR ASENSI, JOSÉ A. CARTÓN, JOSÉ A. MARADONA, JOSÉ M. ASENSI, FRANCISCO PÉREZ, PEDRO REDONDO, ANTONIO LÓPEZ, and JOSÉ M. ARRIBAS

Therapy of brain abscess with impienem—a safe therapeutic choice?
J. Antimicrob. Chemother. 1996 37: 200-203; doi:10.1093/jac/37.1.200 [PDF] [Request Permissions]  

J. A. KARAS, D. G. PILLAY, D. MUCKART, and A. W. STURM

Treatment failure due to extended spectrum ßlactamase
J. Antimicrob. Chemother. 1996 37: 203-204; doi:10.1093/jac/37.1.203 [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.